US Evaluation of Axillary Lymphadenopathy Following COVID-19 Vaccination: A Prospective Longitudinal Study

Editorial Material Medicine, General & Internal

Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer

Diana L. Lam et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Axillary Adenopathy after COVID-19 Vaccine: No Reason to Delay Screening Mammogram

Stacey Wolfson et al.

RADIOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Axillary Lymphadenopathy on Ultrasound after COVID-19 Vaccination and Its Influencing Factors: A Single-Center Study

Ji Yeon Park et al.

Summary: This study aimed to assess the incidence of axillary lymphadenopathy on ultrasound after COVID-19 vaccination and identified factors affecting lymphadenopathy. The results showed that mRNA vaccine type, interval from vaccination, younger age, and first dose were important factors contributing to axillary lymphadenopathy. Breast clinicians should be aware of these side effects and provide accurate information to patients during imaging examinations.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Oncology

Ipsilateral Lymphadenopathy After COVID-19 Vaccination in Patients With Newly Diagnosed Breast Cancer

Su Min Ha et al.

Summary: This study evaluated the imaging and pathological findings in axillary lymph nodes in patients with breast cancer who received concurrent COVID-19 vaccination. The results showed that axillary lymphadenopathy was commonly observed, but there were no specific differential imaging features. Therefore, cautious interpretation of axillary imaging is necessary to avoid overestimation or underestimation of the disease burden.

JOURNAL OF BREAST CANCER (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI)

Simone Schiaffino et al.

Summary: Unilateral axillary lymphadenopathy is a common side effect of COVID-19 vaccination, and the European Society of Breast Imaging has proposed ten recommendations to standardize its management and reduce unnecessary procedures, emphasizing the importance of individualized assessment and appropriate imaging techniques.

INSIGHTS INTO IMAGING (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel

Anton S. Becker et al.

Summary: Vaccination-associated adenopathy is a common imaging finding after COVID-19 vaccination, which may be mistaken for malignant nodal involvement in patients with cancer. Routine imaging should be scheduled at least 6 weeks after vaccination, while clinically indicated imaging should not be delayed.

RADIOLOGY (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients

Can Ozutemiz et al.

Summary: Axillary lymphadenopathy following COVID-19 vaccination can mimic metastasis in vulnerable oncologic patients. However, it is actually a reactive response caused by vaccination. Understanding this phenomenon can prevent unnecessary interventions and treatments.

RADIOLOGY (2021)

添加到收藏夹

Review Immunology

SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond

Emily Bettini et al.

Summary: To successfully protect against pathogen infection, a vaccine must trigger efficient adaptive immunity involving B and T cell responses. mRNA vaccines have become leaders in the race to develop an effective COVID-19 vaccine due to their rapid development capabilities and ability to induce robust adaptive immune responses.

VACCINES (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG PET-CT and relevance to study interpretation

Dan Cohen et al.

Summary: The study investigated the incidence of VAHL after BNT162b2 vaccination and its relevance to PET-CT interpretation in oncologic patients. VAHL was found to be more common and with higher intensity following the booster dose of the vaccine. It is recommended to schedule PET-CT scans during time intervals with lower incidence of VAHL to avoid false or equivocal reports in oncology patients.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination

Yael Eshet et al.

RADIOLOGY (2021)

添加到收藏夹

Letter Oncology

Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination

Kristin A. Robinson et al.

JAMA ONCOLOGY (2021)

添加到收藏夹

Letter Oncology

Association of COVID-19 mRNA Vaccine With Ipsilateral Axillary Lymph Node Reactivity on Imaging

Mehmet Emin Adin et al.

JAMA ONCOLOGY (2021)

添加到收藏夹

Review Immunology

Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines

Ger T. Rijkers et al.

Summary: Infection with SARS-CoV-2 leads to the pandemic disease COVID-19, but effective vaccines such as mRNA and viral vector vaccines have been developed to control the spread. These vaccines can induce immune-related side effects like allergic reactions and thrombosis events, especially in rare cases.

VACCINES (2021)

添加到收藏夹

Article Immunology